Market Cap Rank: Returns for Regeneron Pharmaceuticals, Inc. (REGN)
REGN has no dividends.
Table and Chart of REGN Performance
See what a $1,000 investment in REGN is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| REGN Returns | |
|---|---|
| Start Date | Dec-31-2014 |
| Start Price | $410.25 |
| End Date | Dec-10-2024 |
| End Price | $778.50 |
| # Prices | 121 |
| Min Date | Sep-30-2019 |
| Min Price | $277.40 |
| Max Date | Aug-30-2024 |
| Max Price | $1,184.69 |
| Total Return | 89.76% |
| Annualized Return | 6.56% |
| Current Value of $1,000 Purchase | $1,898 |
| Number Returns | 7,260 |
| Average Return | 46.18% |
| Number Profitable Returns | 5,563 |
| Percent Profitable Returns | 76.63% |
| Number Unprofitable Returns | 1,697 |
| Percent Unprofitable Returns | 23.37% |
| Profitable to Unprofitable Returns Ratio | 3.28 |
| REGN Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | 14.250 | Price to Sales | 17.24 |
| Earnings per Share | $0.0000 |
| PE Ratio | 4598000000 |
| PE to Growth Ratio | 19.48 |
| Price to Book | 6.25 |
| PRICE DATA | |
| 52 Week High | $0.142 |
| 52 Week Low | $1211.2 |
| Analyst Target Price | $0.106 |
| 50-Day Moving Average | $735.95 |
| 200-Day Moving Average | $882.59 |
| FINANCIAL DATA | |
| Revenue per Share | $40.46 |
| Revenue | $0 |
| Profit Margin | 12869% |
| Return on Equity | 7.41% |
| Stock Dividend, Valuation, Price and Financial Data Input | |